Functional Outcome in People at High Risk for Psychosis Predicted by Thalamic Glutamate Levels and Prefronto-Striatal Activation

Schizophrenia Bulletin

Volumn 41, Issue 2, 2015, Pages 429-439

  Allen, Paul ^a   Chaddock, Christopher A ^a   Egerton, Alice ^a   Howes, Oliver D ^a   Barker, Gareth ^a   Bonoldi, Ilaria ^a,b   Fusar Poli, Paolo ^a   Murray, Robin ^a   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

functional MRI; functional outcomes; glutamate; psychosis; spectroscopy; ultra high risk

Indexed keywords

CHLORPROMAZINE; CITALOPRAM; GLUTAMIC ACID; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; BRAIN LEVEL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK POPULATION; HUMAN; INFERIOR FRONTAL GYRUS; INSULA; LOW DRUG DOSE; MALE; MULTIMODAL IMAGING; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; PUTAMEN; SUBCORTEX; SUPERIOR FRONTAL GYRUS; THALAMUS; WECHSLER ADULT INTELLIGENCE SCALE; YOUNG ADULT; METABOLISM; NEOSTRIATUM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; RISK;

ADULT; FEMALE; FOLLOW-UP STUDIES; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIMODAL IMAGING; NEOSTRIATUM; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; RISK; THALAMUS; YOUNG ADULT;

EID: 84940866623     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu115     Document Type: Article

References (47)

1. Hafner H. Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand Suppl. 2000;407:44-48.
2. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69:220-229.
3. Mechelli A, Riecher-Rössler A, Meisenzahl EM, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 2011;68:489-495.
4. Allen P, Luigjes J, Howes OD, et al. Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophr Bull. 2012;38:1268-1276.
5. Howes OD, Bose SK, Turkheimer F, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168:1311-1317.
6. Lin A, Nelson B, Yung AR. 'At-risk' for psychosis research: where are we heading? Epidemiol Psychiatr Sci. 2012;30:1-6.
7. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33:673-681.
8. Lin A, Wood SJ, Nelson B, et al. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res. 2012;132:1-7.
9. Fusar-Poli P, Meneghelli A, Valmaggia L, et al. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br J Psychiatry. 2009;194:181-182.
10. Carrión RE, McLaughlin D, Goldberg TE, et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013;70:1133-1142.
11. Carrión RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry. 2011;168:806-813.
12. Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry. 2005;62:254-262.
13. Broome MR, Matthiasson P, Fusar-Poli P, et al. Neural correlates of executive function and working memory in the 'atrisk mental state'. Br J Psychiatry. 2009;194:25-33.
14. Fusar-Poli P, Stone JM, Broome MR, et al. Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry. 2011;68:881-890.
15. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199-214.
16. Morgan CJ, Curran HV. Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl). 2006;188:408-424.
17. Fu CH, Abel KM, Allin MP, et al. Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2005;183:92-102.
18. Egerton AS, JM. Chaddock, CA. Barker, G. Bonoldi, I. Allen, P. Howes, H. McGuire, P. Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis [published online ahead of print June 11, 2014]. Neuropsychopharmacology.
19. Fusar-Poli P, Howes OD, Allen P, et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry. 2011;16:67-75.
20. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex. 1978;14:234-244.
21. Coren S. Measurement of handedness via self-report: the relationship between brief and extended inventories. Percept Mot Skills. 1993;76:1035-1042.
22. Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and support in south London (OASIS), 2001- 2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry. 2013;28:315-326.
23. Yung AR, Phillips LJ, McGorry PD, et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl. 1998;172:14-20.
24. Hall RC. Global assessment of functioning. A modified scale. Psychosomatics. 1995;36:267-275.
25. Fu CH, Morgan K, Suckling J, et al. A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demand. Neuroimage. 2002;17:871-879.
26. Stone JM, Day F, Tsagaraki H, et al. OASIS. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry. 2009;66:533-539.
27. Takizawa R, Kasai K, Kawakubo Y, et al. Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophr Res. 2008;99:250-262.
28. Moss HE, Abdallah S, Fletcher P, et al. Selecting among competing alternatives: selection and retrieval in the left inferior frontal gyrus. Cereb Cortex. 2005;15:1723-1735.
29. Smith EE, Jonides J. Neuroimaging analyses of human working memory. Proc Natl Acad Sci U S A. 1998;95:12061-12068.
30. Sabb FW, van Erp TG, Hardt ME, et al. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res. 2010;116:173-183.
31. Allen P, Seal ML, Valli I, et al. Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. Schizophr Bull. 2011;37:746-756.
32. Schmidt A, Smieskova R, Aston J, et al. Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication. JAMA Psychiatry. 2013;70:903-912.
33. Yaakub SN, Dorairaj K, Poh JS, et al. Preserved working memory and altered brain activation in persons at risk for psychosis. Am J Psychiatry. 2013;170:1297-1307.
34. Schlösser RG, Koch K, Wagner G, et al. Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study. Neuropsychologia. 2008;46:336-347.
35. Tan HY, Sust S, Buckholtz JW, et al. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. Am J Psychiatry. 2006;163:1969-1977.
36. Théberge J, Bartha R, Drost DJ, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry. 2002;159:1944-1946.
37. Théberge J, Williamson KE, Aoyama N, et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry. 2007;191:325-334.
38. Aoyama N, Théberge J, Drost DJ, et al. Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia. Br J Psychiatry. 2011;198:448-456.
39. Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull. 2013;39:120-129.
40. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13-20.
41. Barch DM, Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci. 2012;16:27-34.
42. Zikopoulos B, Barbas H. Parallel driving and modulatory pathways link the prefrontal cortex and thalamus. PLoS One. 2007;2:e848.
43. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-381.
44. Woodward ND, Karbasforoushan H, Heckers S. Thalamocortical dysconnectivity in schizophrenia. Am J Psychiatry. 2012;169:1092-1099.
45. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ. 2013;346:f185.
46. Borgwardt SJ, Riecher-Rössler A, Dazzan P, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry. 2007;61:1148-1156.
47. Carletti F, Woolley JB, Bhattacharyya S, et al. Alterations in white matter evident before the onset of psychosis. Schizophr Bull. 2012;38:1170-1179.